SAB Biotherapeutics, Inc. (SABSW) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.79 | +78.5% |
| 2024 | $-3.68 | +51.8% |
| 2023 | $-7.64 | -77.3% |
| 2022 | $-4.31 | -584.1% |
| 2021 | $-0.63 | -185.1% |
| 2020 | $0.74 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.79 | +78.5% |
| 2024 | $-3.68 | +51.8% |
| 2023 | $-7.64 | -77.3% |
| 2022 | $-4.31 | -584.1% |
| 2021 | $-0.63 | -185.1% |
| 2020 | $0.74 | — |